40 results
424B3
INM
InMed Pharmaceuticals Inc
13 Nov 23
Prospectus supplement
5:05pm
commercializes such products. We access rare cannabinoids via all non-extraction approaches, including chemical synthesis, biosynthesis and our proprietary
424B3
hocbanuemp32nzq
19 Oct 22
Prospectus supplement
6:10am
424B3
st71wkj 62cy
6 Jul 22
Prospectus supplement
2:43pm
424B5
7u43osi07h5v 1gjupm
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
xb50 u0hq95fzv
25 Apr 22
Prospectus supplement
5:02pm
424B3
mqmy20
7 Apr 22
Prospectus supplement
4:46pm